Transcription and RNA Processing (1B)

Historical Context & Motivation

The concept that genetic information flows from DNA to RNA to protein—the central dogma of molecular biology—emerged from a series of landmark discoveries spanning the mid-twentieth century. Before the molecular details of transcription were elucidated, the relationship between genes and their functional products remained deeply mysterious. Early geneticists could observe phenotypic traits and map loci, yet the chemical mechanism by which a segment of DNA directed the synthesis of a polypeptide was entirely unknown. The discovery of RNA as a transient informational intermediate resolved this gap, establishing transcription as the first regulated step in gene expression and opening a vast new frontier in molecular biology.

These milestones collectively defined the molecular pathway by which information encoded in double-stranded DNA is transcribed into single-stranded RNA and subsequently processed into a translatable message. For the MCAT, understanding this pathway is essential because it connects nucleic acid biochemistry to the regulation of gene expression, protein synthesis, and ultimately cellular function. The central question this lesson addresses is: How does RNA polymerase read a DNA template to produce RNA, and what co-transcriptional and post-transcriptional modifications convert the primary transcript into a functional mRNA?

Core Principles of Transcription

Transcription is the enzyme-catalyzed synthesis of an RNA strand complementary to one strand of a DNA duplex. In eukaryotes, this process is carried out primarily by three nuclear RNA polymerases, each dedicated to a distinct class of RNA gene product. The polymerase most relevant to mRNA production—and the most heavily tested on the MCAT—is RNA Polymerase II (Pol II). Unlike DNA replication, transcription does not require a primer; the polymerase initiates de novo at a promoter site and reads the template (antisense) strand in the 3ʹ → 5ʹ direction, synthesizing the nascent RNA in the 5ʹ → 3ʹ direction. The resulting RNA is complementary to the template strand and identical in sequence (with uracil replacing thymine) to the coding (sense) strand.

Visual Overview of Eukaryotic Transcription

Several features of the diagram merit close attention for MCAT preparation. First, note that the transcription bubble encompasses approximately 12–17 base pairs of unwound DNA, within which an 8-base-pair RNA–DNA hybrid exists. The polymerase maintains this transient structure as it advances, re-annealing the DNA duplex behind it. Second, the C-terminal domain (CTD) of Pol II's Rpb1 subunit serves as a dynamic recruiting platform: phosphorylation of Ser5 by TFIIH during initiation recruits capping enzymes, whereas phosphorylation of Ser2 by P-TEFb during elongation recruits splicing and polyadenylation factors. This 'CTD code' couples transcription to RNA processing, ensuring that capping, splicing, and 3ʹ-end formation occur in a temporally coordinated manner.

Mechanistic Details of Transcription

Initiation: Assembling the Pre-Initiation Complex

Eukaryotic transcription initiation is a multi-step process requiring the ordered assembly of general transcription factors (GTFs) at the core promoter. The sequence of events typically begins when TFIID—whose TBP (TATA-binding protein) subunit recognizes and bends the TATA box—binds the promoter. This is followed by recruitment of TFIIA and TFIIB, which stabilize the TBP–DNA complex. TFIIF then escorts Pol II to the promoter, and finally TFIIE and TFIIH join to complete the pre-initiation complex (PIC). TFIIH possesses two critical enzymatic activities: a helicase that unwinds ~11 bp of DNA around the transcription start site to form the open complex, and a kinase that phosphorylates Ser5 of the CTD heptad repeats, triggering promoter clearance.

Elongation: Processive RNA Synthesis

Once Pol II clears the promoter, it enters a highly processive elongation phase, incorporating ribonucleoside triphosphates (rNTPs) at a rate of approximately 20–40 nucleotides per second. The chemistry of each nucleotide addition step involves a nucleophilic attack by the 3ʹ-OH of the growing RNA chain on the α-phosphate of the incoming rNTP, releasing pyrophosphate (PP_i). This is thermodynamically driven forward by the subsequent hydrolysis of PP_i to 2 P_i by pyrophosphatase. Elongation factors such as TFIIS assist by stimulating the intrinsic endonuclease activity of Pol II when the enzyme backtracks, enabling proofreading of the nascent transcript. Note that RNA polymerase has a significantly higher error rate (~10⁻⁴ to 10⁻⁵) compared to the replicative DNA polymerase (~10⁻⁹ to 10⁻¹⁰), reflecting the absence of a dedicated 3ʹ → 5ʹ exonuclease proofreading domain.

Termination: Cleavage-Polyadenylation and Pol II Release

Termination of Pol II transcription is coupled to 3ʹ-end processing of the pre-mRNA. As Pol II transcribes through the poly(A) signal sequence (AAUAAA), the cleavage and polyadenylation specificity factor (CPSF) and cleavage stimulation factor (CstF)—recruited via the Ser2-phosphorylated CTD—bind the nascent RNA. The transcript is cleaved ~10–30 nucleotides downstream of the AAUAAA signal, and poly(A) polymerase (PAP) adds approximately 200 adenylate residues to the free 3ʹ-OH. Two models explain subsequent Pol II dissociation. The torpedo model proposes that a 5ʹ → 3ʹ exonuclease (Rat1/XRN2) degrades the uncapped RNA emerging from the polymerase, eventually catching Pol II and triggering its release. The allosteric model posits that passage through the poly(A) signal induces conformational changes in the elongation complex, destabilizing it.

Post-Transcriptional RNA Processing in Eukaryotes

The primary transcript produced by Pol II, termed pre-mRNA (heterogeneous nuclear RNA, hnRNA), undergoes three major co-transcriptional and post-transcriptional modifications before it is exported from the nucleus as a mature mRNA competent for translation: 5ʹ capping, RNA splicing, and 3ʹ polyadenylation. These modifications are essential for mRNA stability, nuclear export, and efficient translation initiation.

5ʹ Capping

The 5ʹ cap is added co-transcriptionally once the nascent transcript is approximately 20–30 nucleotides long. The capping process involves three enzymatic activities: (1) an RNA triphosphatase removes the γ-phosphate from the 5ʹ end, (2) a guanylyltransferase adds a GMP residue via an unusual 5ʹ-5ʹ triphosphate linkage, and (3) a methyltransferase adds a methyl group to the N-7 position of the guanine, yielding m⁷GpppN. Functionally, the cap protects mRNA from 5ʹ exonuclease degradation, promotes ribosome recruitment via recognition by the translation initiation factor eIF4E, and facilitates first intron splicing.

RNA Splicing and the Spliceosome

Intron removal is catalyzed by the spliceosome, a large ribonucleoprotein complex composed of five small nuclear ribonucleoproteins (snRNPs: U1, U2, U4, U5, U6) and numerous associated proteins. Splicing relies on three conserved sequence elements within each intron: the 5ʹ splice site (GU), the branch point adenosine (typically within a YNYURAY consensus), and the 3ʹ splice site (AG). The mechanism proceeds via two sequential transesterification reactions. In the first, the 2ʹ-OH of the branch point adenosine attacks the phosphodiester bond at the 5ʹ splice site, generating a lariat intermediate with a 2ʹ–5ʹ phosphodiester branch. In the second, the free 3ʹ-OH of the upstream exon attacks the 3ʹ splice site, ligating the two exons and releasing the lariat intron for degradation. Critically, the catalytic core of the spliceosome is RNA-based—U6 and U2 snRNAs form the active site—making it a ribozyme.

Alternative Splicing

A single gene can produce multiple mRNA isoforms through alternative splicing, a process regulated by SR proteins (serine/arginine-rich) and hnRNPs (heterogeneous nuclear ribonucleoproteins) that bind exonic or intronic splicing enhancers and silencers. Patterns of alternative splicing include exon skipping (cassette exons), mutually exclusive exons, alternative 5ʹ or 3ʹ splice site selection, and intron retention. It is estimated that greater than 95% of human multi-exon genes undergo alternative splicing, vastly expanding proteomic diversity from a finite genome.

3ʹ Polyadenylation

Following endonucleolytic cleavage 10–30 nt downstream of the AAUAAA hex­anucleotide, poly(A) polymerase (PAP) catalyzes the template-independent addition of approximately 200 adenylate residues to form the poly(A) tail. Poly(A)-binding protein (PABP) coats the tail and protects it from 3ʹ exonuclease-mediated shortening. The poly(A) tail serves multiple functions: it enhances mRNA stability by counteracting deadenylase activity, facilitates nuclear export, and promotes translation initiation through PABP-mediated circularization of the mRNA in cooperation with eIF4G.

Worked Example: Predicting mRNA Products from a Gene Map

Consider a hypothetical eukaryotic gene with the following structure: a promoter containing a TATA box at −28, a transcription start site at +1, three exons (E1: 120 nt, E2: 300 nt, E3: 180 nt), two introns (I1: 1,500 nt, I2: 2,000 nt), and a poly(A) signal (AAUAAA) located 20 nt downstream of the E3 stop codon within the 3ʹ UTR. The question asks: What is the approximate length of the mature mRNA, and what processing events are required to generate it?

Prokaryotic vs. Eukaryotic Transcription and Processing

A thorough understanding of the differences between prokaryotic and eukaryotic transcription is essential for the MCAT, as passage-based questions frequently require you to identify which features belong to which domain. The following table highlights the most critical distinctions.

Connection to Gene Regulation and Disease

Transcription and RNA processing are not merely biochemical events—they represent critical nodes for the regulation of gene expression. Aberrations in these processes underlie numerous human diseases and serve as targets for pharmacological intervention. Understanding these connections extends your mastery of transcription into the domains of molecular pathology and epigenetic regulation, both of which appear on the MCAT.

These advanced topics intersect with MCAT content areas including signal transduction (how extracellular signals ultimately modulate transcription factor activity), cancer biology (oncogenes often encode constitutively active transcription factors such as Myc), and pharmacology (rifampicin targeting bacterial RNA polymerase as an antibiotic, α-amanitin as a Pol II poison from Amanita mushrooms, and antisense oligonucleotides like nusinersen targeting splicing to treat SMA). Mastery of the foundational transcription and processing machinery provides the scaffolding upon which these clinically relevant extensions build.

Practice Problems

Lesson Summary